Please try another search
For the fiscal year ended 31 December 2018, CAS Medical Systems Inc revenues increased 17% to $21.9M. Net loss applicable to common stockholders excluding extraordinary items increased from $1.4M to $7.7M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Selling, general and administrative increase of 4% to $14M (expense).
Period Ending: | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
---|---|---|---|---|
Total Revenue | 5.8 | 5.38 | 5.29 | 5.44 |
Gross Profit | 3.3 | 3.14 | 3.18 | 3.09 |
Operating Income | -1.24 | -0.98 | -1.13 | -1.15 |
Net Income | -1.54 | -1.28 | -1.72 | -1.42 |
Period Ending: | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
---|---|---|---|---|
Total Assets | 10.85 | 11.73 | 12.69 | 11.66 |
Total Liabilities | 13.11 | 12.65 | 12.58 | 10.18 |
Total Equity | -2.26 | -0.92 | 0.11 | 1.48 |
Period Ending: | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
---|---|---|---|---|
Period Length: | 12 Months | 9 Months | 6 Months | 3 Months |
Cash From Operating Activities | -2.63 | -2.36 | -1.18 | -0.12 |
Cash From Investing Activities | -0.86 | -0.62 | -0.48 | -0.22 |
Cash From Financing Activities | 1.12 | 1.19 | 1.2 | -0.55 |
Net Change in Cash | -2.38 | -1.79 | -0.46 | -0.89 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review